N@N

DALLAS--([ BUSINESS WIRE ])--[ Kendall Law Group ], led by former federal judge Joe Kendall, is investigating ZOLL Medical Corporation (NASDAQ:ZOLL) for shareholders in connection with the proposed acquisition by Asahi Kasei Corporation. The national securities firmas investigation seeks to determine whether ZOLL and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a ZOLL shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at [ investor@kendalllawgroup.com ].

On March 12, 2012, the companies announced the definitive merger agreement under which ZOLL would be acquired by Asahi Kasei, in a transaction valued at approximately $2.21 billion. Under the terms of the agreement, ZOLL stockholders will receive $93.00 in cash for each share of ZOLL common stock held. According to Thompson/First Call, at least one analyst has set a price target of $100.00 per share for ZOLLas stock. The firmas investigation seeks to determine whether ZOLL and its Board undertook a fair process in negotiating the deal.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.